Insiders · RANI

RANI insider transactions

Rani Therapeutics Holdings Inc. (RANI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for RANI

• 14d
  SEC Form 4 filed by Chief Business Officer Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 14d
  SEC Form 4 filed by Chief Technical Officer Javadi Alireza

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 14d
  SEC Form 4 filed by Chief Executive Officer Imran Talat

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 18d
  SEC Form 4 filed by Director Bassan Abraham

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 18d
  SEC Form 4 filed by Director Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 18d
  SEC Form 4 filed by Director Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 18d
  SEC Form 4 filed by Director Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 18d
  SEC Form 4 filed by Director Bailey Vasudev Jaiprakash

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 18d
  SEC Form 4 filed by Director Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 84d
  SEC Form 3 filed by new insider Javadi Alireza

  3 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 232d
  SEC Form 4 filed by Director Bailey Vasudev Jaiprakash

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 232d
  SEC Form 3 filed by new insider Bailey Vasudev Jaiprakash

  3 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 235d
  SEC Form 4 filed by Director Bassan Abraham

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 235d
  SEC Form 3 filed by new insider Bassan Abraham

  3 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 235d
  Director Imran Mir A bought $1,260,417 worth of shares (2,083,334 units at $0.60) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 240d
  Large owner South Cone Investments Limited Partnership sold $15,711,314 worth of shares (5,923,000 units at $2.65) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 318d
  SEC Form 4 filed by Chief Business Officer Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 385d
  SEC Form 4 filed by Director Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 385d
  SEC Form 4 filed by Director Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 385d
  SEC Form 4 filed by Director Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 385d
  SEC Form 4 filed by Director Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 385d
  SEC Form 4 filed by Director Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 385d
  SEC Form 4 filed by Director Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 392d
  SEC Form 4 filed by Chief Scientific Officer Hashim Mir

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 392d
  SEC Form 4 filed by Chief Business Officer Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 392d
  SEC Form 4 filed by Chief Executive Officer Imran Talat

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 392d
  SEC Form 4 filed by Chief Financial Officer Sanford Svai S

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 549d
  SEC Form 4 filed by Director Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 549d
  SEC Form 4 filed by Director Debuono Laureen

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 549d
  SEC Form 4 filed by Director Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 549d
  SEC Form 4 filed by Director Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 549d
  SEC Form 4 filed by Director Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 549d
  SEC Form 4 filed by Director Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 549d
  SEC Form 4 filed by Director Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 550d
  Chief Business Officer Mckinley Kate bought $29,993 worth of shares (17,960 units at $1.67) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 556d
  Chief Executive Officer Imran Talat bought $19,974 worth of shares (10,296 units at $1.94), increasing direct ownership by 2% to 494,751 units (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 610d
  Large owner South Cone Investments Limited Partnership sold $10,141,674 worth of shares (3,829,360 units at $2.65) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 750d
  SEC Form 4 filed by Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 750d
  SEC Form 4 filed by Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 750d
  SEC Form 4 filed by Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 750d
  SEC Form 4 filed by Debuono Laureen

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 750d
  SEC Form 4 filed by Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 750d
  SEC Form 4 filed by Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 750d
  SEC Form 4 filed by Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 819d
  SEC Form 4 filed by Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 819d
  SEC Form 4 filed by Hashim Mir

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 819d
  SEC Form 4 filed by Groen Eric

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 819d
  SEC Form 4 filed by Imran Talat

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 819d
  SEC Form 4 filed by Sanford Svai S

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 913d
  SEC Form 4 filed by Hashim Mir

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 913d
  SEC Form 4 filed by Sanford Svai S

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 913d
  SEC Form 4 filed by Imran Talat

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 913d
  SEC Form 4 filed by Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 913d
  SEC Form 4 filed by Groen Eric

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 913d
  SEC Form 4 filed by Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 913d
  SEC Form 4 filed by Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 913d
  SEC Form 4 filed by Debuono Laureen

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 913d
  SEC Form 4 filed by Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 913d
  SEC Form 4 filed by Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 913d
  SEC Form 4 filed by Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)